Latest Class Actions News

Page 2 of 14
Telix Pharmaceuticals delivered a strong 56% revenue increase in 2025, driven by U.S. sales of Illuccix and the launch of Gozellix, while advancing its therapeutic pipeline and expanding global manufacturing capabilities. Despite a net loss, the company is investing heavily in R&D and sustainability initiatives aligned with climate-related disclosures.
Ada Torres
Ada Torres
20 Feb 2026
Mayne Pharma has initiated legal proceedings against Cosette Pharmaceuticals and associated parties, seeking substantial damages following the collapse of their acquisition deal.
Ada Torres
Ada Torres
18 Feb 2026
BHP Group Limited reported a robust half-year to December 2025, with copper overtaking iron ore as the top earnings contributor and a detailed technical assessment released for its promising Vicuña copper-gold project.
Maxwell Dee
Maxwell Dee
17 Feb 2026
JB Hi-Fi has reported a solid 7.3% increase in revenue and a 7.1% rise in net profit for the half-year ended December 2025, alongside a fully franked interim dividend of 210 cents per share.
Logan Eniac
Logan Eniac
16 Feb 2026
Paladin Energy reported a 16% increase in uranium production and a significant rise in sales volumes for the December 2025 quarter, alongside a successful equity raise and debt restructuring that enhance its financial flexibility.
Maxwell Dee
Maxwell Dee
12 Feb 2026
AMP Limited reported a robust FY25 with underlying NPAT up 20.8%, driven by strong cashflow growth, cost reductions, and new product launches including AMP Bank GO and AMP Lifetime Pension. The company sets a steady course for FY26 with continued focus on retirement solutions and AI-driven innovation.
Victor Sage
Victor Sage
12 Feb 2026
AMP Limited reported a 20.8% rise in underlying net profit after tax for 2025, driven by growth in wealth platforms and investments, alongside a planned CEO transition and pending class action settlements.
Claire Turing
Claire Turing
12 Feb 2026
Insurance Australia Group’s half year net profit fell 35% to $505 million, weighed down by natural peril claims and integration costs from its RACQI acquisition. Despite this, the insurer maintains its full-year guidance and announces a $200 million share buy-back.
Victor Sage
Victor Sage
12 Feb 2026
ASB’s half-year results show a modest 1% rise in cash net profit, driven by growth in home, business, and rural lending alongside a 5% increase in customer deposits. The bank is investing heavily in technology, customer experience, and social housing initiatives to support New Zealand’s long-term prosperity.
Claire Turing
Claire Turing
11 Feb 2026
Commonwealth Bank of Australia reported a 5% increase in statutory net profit after tax to $5.367 billion for the half year ended December 2025, supported by lending growth and improved credit quality despite margin pressures and higher expenses. The bank declared a fully franked interim dividend of $2.35 per share.
Claire Turing
Claire Turing
11 Feb 2026
News Corporation reported a 4% revenue increase to US$4.506 billion for the half-year ended December 2025, while net income declined 9% to US$305 million. The company declared an interim dividend and continued its stock repurchase program amid mixed segment performances and ongoing legal challenges.
Elise Vega
Elise Vega
9 Feb 2026
Acusensus Limited has settled its patent litigation with Redflex Traffic Systems, issuing over six million shares and paying US$6 million in cash to resolve the dispute. The agreement clears the way for Acusensus to continue its road safety technology operations unimpeded.
Sophie Babbage
Sophie Babbage
6 Feb 2026